Search Results
Results found for "Brian Arey"
- Antonella Di Pizio: Computational Pharmacology of Taste and Olfactory Receptors | Dr. GPCR Ecosystem
Bitter taste receptors have been identified in the heart and intestine, olfactory receptors in the brain knockout mice show anti-anxiety, anti-depressant phenotypes, and expression of the receptor in the brain TAS2Rs have been identified in the heart and intestine; olfactory receptors in the brain.
- Dr. Raul Gainetdinov | Dr. GPCR Ecosystem
Gainetdinov was a Senior Researcher in the Department of Neuroscience and Brain Technologies at the Italian
- Dr. Caron Tribute Part 3 | Dr. GPCR Ecosystem
the mechanisms of action and regulation of hormones and neurotransmitters and how they might underlie brain Bryan Roth (current) Dr. Ali Salahpour (2007) Dr. Lauren Sloksy (2020) Dr. Josh C Snyder (2012) Dr.
- Dr. Jean Martin Beaulieu | Dr. GPCR Ecosystem
Beaulieu has pioneered work establishing a role for Beta-arrestin signaling in the brain in vivo and
- Fluorescent Probes for GLP-1R and GIPR Imaging: From Cell Assays to In Vivo Systems | Dr. GPCR Ecosystem
intake regulation, and inflammation — within complex tissue environments including the pancreas and brain
- Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem
emphasis on understanding how these receptors operate within complex tissues such as the pancreas and brain
- Dr. Claudia Stäubert | Dr. GPCR Ecosystem
shared an example she heard in a podcast about fecal transplants and the relationship between the gut, brain
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
“Your brain’s not a machine. Let it rest.
- Amynah Pradhan: The Delta Opioid Receptor and the Migraine Paradox | Dr. GPCR Ecosystem
The ideal delta agonist, by her account, would be non-internalizing, brain-penetrant, long-half-life,
- GPCR Assay Strategy, Bias, and Translational Drug Discovery | Dr. GPCR Ecosystem
persistent scientific questioning and collaborative networks accelerate GPCR innovation across disease areas Martin Marro leads the Cell Pharmacology group in the Diabetes, Obesity and Complications Therapeutic Area through roles at Novartis and Tectonic Therapeutic, contributing to projects across key therapeutic areas—spanning
- Anything BUT GPCRs with Dr. Mikel Garcia-Marcos | Dr. GPCR Ecosystem
All my formal training was in the area of signal transduction, and I continued to work on this area since
- Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
Kim describes a personal inclination toward challenging research areas. It’s highly expressed in the brain and spinal cord. So Ashish introduced it as a potential project area, and it stuck with me. Dr.
- Graciela Piñeyro: Partial Agonism, Receptor Recycling, and the Limits of Bias | Dr. GPCR Ecosystem
cells in an age of iPSC enthusiasm 30:40 — Cannabinoids, the entourage hypothesis, and THC in teenage brains
- Dr. Daniel Isom | Dr. GPCR Ecosystem
Daniel Isom "Dan was born and raised in the Cleveland area.
- Dr. David Sykes | Dr. GPCR Ecosystem
significant contribution to the understanding of agonist/ antagonist GPCR kinetic determinants in an area
- Gáspár Pándy-Szekeres | Dr. GPCR Ecosystem
an automated chimeric homology modeling pipeline for GPCRs and since have branched out to multiple areas
- Dr. Lukas Grätz | Dr. GPCR Ecosystem
an automated chimeric homology modeling pipeline for GPCRs and since have branched out to multiple areas
- Dr. Khaled Abdelrahman | Dr. GPCR Ecosystem
signaling are regulated in a sex-selective manner and how this can influence drug discovery in the area
- Antony Boucard: Adhesion GPCRs and the Molecular Code of Synapse Formation | Dr. GPCR Ecosystem
molecular logic of synapse formation and how adhesion molecules encode synaptic specificity in the brain graduate studies, Boucard left an enzymatic reaction on his bench over a weekend — called away for army Mexico City 03:43 The summer lab that changed everything — and why he turned down medical school 10:23 Army
- Dr. Richard Premont | Dr. GPCR Ecosystem
For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling
- Dr. Richard Premont | Dr. GPCR Ecosystem
For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling
- Dr. Richard Premont | Dr. GPCR Ecosystem
For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling
- Dr. Richard Premont | Dr. GPCR Ecosystem
For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling
- Dr. Josephine (Pina) Cardarelli | Dr. GPCR Ecosystem
been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology company in the Bay Area
- Yamina's Corner | Dr. GPCR Ecosystem
Suboptimal CRO Partnerships ❌ Stalled Pipeline Progression ❌ Uncertainty in GPCR Investments Advisory Focus Areas with a focused discussion of your current GPCR program and critical challenges, identifying precise areas
- Foundry for GPCR Organizations | Dr. GPCR Ecosystem
Book a Strategy Call → Our Core Support Areas Discovery Consulting & Strategy Expert guidance to de-risk
- Dr. Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore | Dr. GPCR Ecosystem
signaling are regulated in a sex-selective manner and how this can influence drug discovery in the area
- Dr. Michael Feigin | Dr. GPCR Ecosystem
Mike's lab has two main areas of interest: 1) alternative polyadenylation as a targetable driver of pancreatic conversation ended with Yamina expressing interest in learning more about Mike's two main research areas
- Privacy Policy | Dr. GPCR Ecosystem
site, Ecosystem.DrGPCR.com uses industry-standard encryption to protect data transmissions in certain areas
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
About Alex Serafini Alex was born and raised in the Bay Area and received his BS/MS Neuroscience from



























